Pralatrexate
NDC 65219-550, Pralatrexate, injection, from Fresenius Kabi USA, LLC.
- Product NDC
- 65219-550
- Status
- Listed
- Labeler
- Fresenius Kabi USA, LLC
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA022468
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65219-550 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PRALATREXATE20 mg/mL
Pharmacologic classes
Folate Analog Metabolic Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65219-550-01 | 65219055001 | 1 VIAL, SINGLE-DOSE in 1 CARTON (65219-550-01) / 1 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/a5daa583-4965-4564-ad87-41ffe6c08a11Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=65219-550
Use it
Look up 65219-550 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65219-550 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65219-550. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.